In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...

Reduced daytime physical activity, as measured with wearable trackers, is tied to increased risk for multiple sclerosis progression and brain atrophy, new research shows.

Data from fitness trackers showed not only who was at higher risk of disease progression, but whose brains might be in danger ...

Fred D. Lublin, MD, discusses evolving concepts in MS, including earlier high-efficacy therapy, unrecognized progression, and ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...

People with MS who carry the APOE4 gene variant show greater signs of nerve damage and cognitive decline than those who don't ...

Multiple sclerosis (MS) is a debilitating disease with few treatment options. But in a new clinical trial, scientists have tested a promising new therapy involving injections of stem cells, which ...

“Our data add and expand previous observations on silent progression in MS and are consistent with the view of the disease as a single continuum, in which RAW [relapse-associated worsening] and PIRA ...

Wearable sensors may help identify people with multiple sclerosis (MS) who are more likely to have worsening disability and ...

Disability progression independent of relapse activity (PIRA) -- sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The ...

Multiple sclerosis (MS) is a chronic, often debilitating autoimmune disease that affects the central nervous system (CNS).